Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 8/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9563959 | 0.91 | SMN1; SMN2 (0.41) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL23225387 | 0.91 | SMN1; SMN2 (0.41) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL25993937 | 0.86 | ACHE (0.46) | SMN1; SMN2HTTTSHRMAPK1MEN1 | |
| SCHEMBL18352593 | 0.86 | SMN1; SMN2 (0.49) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL12922582 | 0.86 | TSHR (0.45) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL23448982 | 0.85 | TSHR (0.44) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL26078407 | 0.84 | TSHR (0.45) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL18354885 | 0.83 | HCAR2 (0.47) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL20202285 | 0.83 | TSHR (0.41) | SMN1; SMN2HTTLMNATSHRMAPK1 | |
| SCHEMBL30341925 | 0.83 | TSHR (0.44) | SMN1; SMN2HTTLMNATSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0530141-A1 | Radiation curable composition with high temperature oil resistance | CIBA-GEIGY AG (CH) | 1993-03-03 | — | — | EP | claimed |
| US-12044968-B2 | Protective film-forming composition having acetal structure and amide structure | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12044968-B2 | Protective film-forming composition having acetal structure and amide structure | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-11873426-B2 | Curable composition, cured product, optical member, lens, and compound | FUJIFILM CORPORATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11780819-B2 | Aromatic substituted alkane-core monomers and polymers thereof for volume Bragg gratings | META PLATFORMS TECHNOLOGIES, LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-11718580-B2 | Fluorene derivatized monomers and polymers for volume Bragg gratings | META PLATFORMS TECHNOLOGIES, LLC (US) | 2023-08-08 | — | — | US | disclosed |
| US-11518916-B2 | Lens adhesive, cemented lens, and imaging module | FUJIFILM CORPORATION (JP) | 2022-12-06 | — | — | US | disclosed |
| US-20220153895-A1 | SUBSTITUTED PROPANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2022-05-19 | — | — | US | disclosed |
| WO-2022104137-A1 | SUBSTITUTED PROPANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | FACEBOOK TECHNOLOGIES, LLC (US) | 2022-05-19 | — | — | WO | disclosed |
| US-20220153693-A1 | SUBSTITUTED MONO- AND POLY-PHENYL-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2022-05-19 | — | — | US | disclosed |
| US-20210155581-A1 | AROMATIC SUBSTITUTED ETHANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2021-05-27 | — | — | US | disclosed |
| US-20210155599-A1 | AROMATIC SUBSTITUTED ALKANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2021-05-27 | — | — | US | disclosed |
| US-20210155584-A1 | AROMATIC SUBSTITUTED METHANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2021-05-27 | — | — | US | disclosed |
| US-20200354311-A1 | FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2020-11-12 | — | — | US | disclosed |
| US-20200355997-A1 | THIANTHRENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC | 2020-11-12 | — | — | US | disclosed |
| US-20200325367-A1 | LENS ADHESIVE, CEMENTED LENS, AND IMAGING MODULE | FUJIFILM CORPORATION (JP) | 2020-10-15 | — | — | US | disclosed |
| EP-0530141-A1 | Radiation curable composition with high temperature oil resistance | CIBA-GEIGY AG (CH) | 1993-03-03 | — | — | EP | disclosed |
| US-5183831-A | Acylated polyurethanes | CIBA-GEIGY CORPORATION (US) | 1993-02-02 | — | — | US | disclosed |
| US-5047261-A | Monoacrylated Alkylene Dicarbonate | SOCIETE NATIONALE DES POURDRES ET EXPLOSIFS (FR) | 1991-09-10 | — | — | US | disclosed |
| EP-0263749-A1 | Process for the preparation of radiocrosslinked coatings | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1988-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200325367-A1 | LENS ADHESIVE, CEMENTED LENS, AND IMAGING MODULE | SP1, SPOP, SMC2 | SMN1; SMN2 3208/4885HTT 3689/4885LMNA 1584/4885 |
| US-20220153693-A1 | SUBSTITUTED MONO- AND POLY-PHENYL-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | PARG, PARN, PCBP1 | SMN1; SMN2 3172/4885HTT 874/4885LMNA 1442/4885 |
| US-20200355997-A1 | THIANTHRENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | TST, SMO, BRAP | SMN1; SMN2 2734/4885HTT 419/4885LMNA 4146/4885 |
| US-20200354311-A1 | FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | RHOA, PARG, LSG1 | SMN1; SMN2 791/4885HTT 1089/4885LMNA 1160/4885 |
| US-11718580-B2 | Fluorene derivatized monomers and polymers for volume Bragg gratings | RHOA, PARG, LSG1 | SMN1; SMN2 791/4885HTT 1089/4885LMNA 1160/4885 |
| US-11873426-B2 | Curable composition, cured product, optical member, lens, and compound | RB1, CCNO, SPOP | SMN1; SMN2 2646/4885HTT 2478/4885LMNA 421/4885 |
| US-20210155584-A1 | AROMATIC SUBSTITUTED METHANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | SMAD2, MAFG, MYO1G | SMN1; SMN2 1698/4885HTT 884/4885LMNA 2632/4885 |
| US-20210155599-A1 | AROMATIC SUBSTITUTED ALKANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | SMAD2, ALK, SMAD3 | SMN1; SMN2 2029/4885HTT 1401/4885LMNA 2311/4885 |
| US-20210155581-A1 | AROMATIC SUBSTITUTED ETHANE-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS | SMAD2, KDM2A, SMAD3 | SMN1; SMN2 2895/4885HTT 437/4885LMNA 2661/4885 |
| US-11780819-B2 | Aromatic substituted alkane-core monomers and polymers thereof for volume Bragg gratings | SMAD2, ALK, SMAD3 | SMN1; SMN2 2029/4885HTT 1401/4885LMNA 2311/4885 |
| US-11518916-B2 | Lens adhesive, cemented lens, and imaging module | SP1, SPOP, SMC2 | SMN1; SMN2 3208/4885HTT 3689/4885LMNA 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.